Advertisement

Index by author

February 01, 1993; Volume 43,Issue 2

A

  1. Abe, H

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  2. Allison, A C

    1. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
      Y Amano, S W Lee and A C Allison
      Molecular Pharmacology February 1993, 43 (2) 176-182;

  3. Amano, Y

    1. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
      Y Amano, S W Lee and A C Allison
      Molecular Pharmacology February 1993, 43 (2) 176-182;

  4. Anders, E M

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  5. Aramori, I

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  6. Arellano, L

    1. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
      M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
      Molecular Pharmacology February 1993, 43 (2) 200-206;

  7. Asaoka, K

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

B

  1. Barnes, P J

    1. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
      P C Ring, P M Seldon, P J Barnes and M A Giembycz
      Molecular Pharmacology February 1993, 43 (2) 302-312;

  2. Boer, R

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  3. Burkitt, M J

    1. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
      M J Burkitt, M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology February 1993, 43 (2) 257-263;

  4. Burrows, G G

    1. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action.
      F F Moebius, G G Burrows, J Striessnig and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 139-148;

C

  1. Cai, J J

    1. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
      T K Chatterjee, J A Moy, J J Cai, H C Lee and R A Fisher
      Molecular Pharmacology February 1993, 43 (2) 167-175;

  2. Chatterjee, T K

    1. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
      T K Chatterjee, J A Moy, J J Cai, H C Lee and R A Fisher
      Molecular Pharmacology February 1993, 43 (2) 167-175;

  3. Chu, D T

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  4. Ciesla, W

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  5. Coleman, B A

    1. Identification of the benzomorphan opiate binding site on the catalytic subunit of acetylcholinesterase.
      B A Coleman and R E Oswald
      Molecular Pharmacology February 1993, 43 (2) 217-225;

  6. Conway, B R

    1. Regulation of phosphatidylinositol 4-kinase activity in rat pancreatic acini.
      B R Conway, M Withiam-Leitch and R P Rubin
      Molecular Pharmacology February 1993, 43 (2) 286-292;

  7. Costa, T

    1. Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
      H O Onaran, T Costa and D Rodbard
      Molecular Pharmacology February 1993, 43 (2) 245-256;

D

  1. de Morais, S M

    1. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
      L S Kaminsky, S M de Morais, M B Faletto, D A Dunbar and J A Goldstein
      Molecular Pharmacology February 1993, 43 (2) 234-239;

  2. Denison, M S

    1. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
      M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
      Molecular Pharmacology February 1993, 43 (2) 200-206;

  3. Dunbar, D A

    1. Rat small intestinal cytochromes P450 probed by warfarin metabolism.
      M J Fasco, J B Silkworth, D A Dunbar and L S Kaminsky
      Molecular Pharmacology February 1993, 43 (2) 226-233;
    2. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
      L S Kaminsky, S M de Morais, M B Faletto, D A Dunbar and J A Goldstein
      Molecular Pharmacology February 1993, 43 (2) 234-239;

E

  1. Eskildsen, L A

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

F

  1. Faletto, M B

    1. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
      L S Kaminsky, S M de Morais, M B Faletto, D A Dunbar and J A Goldstein
      Molecular Pharmacology February 1993, 43 (2) 234-239;

  2. Fasco, M J

    1. Rat small intestinal cytochromes P450 probed by warfarin metabolism.
      M J Fasco, J B Silkworth, D A Dunbar and L S Kaminsky
      Molecular Pharmacology February 1993, 43 (2) 226-233;

  3. Felder, R A

    1. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
      A Horiuchi, K Takeyasu, M M Mouradian, P A Jose and R A Felder
      Molecular Pharmacology February 1993, 43 (2) 281-285;

  4. Fisher, R A

    1. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
      T K Chatterjee, J A Moy, J J Cai, H C Lee and R A Fisher
      Molecular Pharmacology February 1993, 43 (2) 167-175;

  5. Flockerzi, D

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  6. Flores, L R

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  7. Follesa, P

    1. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system.
      P Follesa and I Mocchetti
      Molecular Pharmacology February 1993, 43 (2) 132-138;

  8. Fuhr, U

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

G

  1. Giembycz, M A

    1. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
      P C Ring, P M Seldon, P J Barnes and M A Giembycz
      Molecular Pharmacology February 1993, 43 (2) 302-312;

  2. Glossmann, H

    1. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action.
      F F Moebius, G G Burrows, J Striessnig and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 139-148;
    2. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  3. Goldstein, J A

    1. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
      L S Kaminsky, S M de Morais, M B Faletto, D A Dunbar and J A Goldstein
      Molecular Pharmacology February 1993, 43 (2) 234-239;

  4. Groom, K R

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

H

  1. Hanna, P M

    1. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
      M J Burkitt, M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology February 1993, 43 (2) 257-263;

  2. Hoeltje, H D

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  3. Horie, T

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  4. Horiuchi, A

    1. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
      A Horiuchi, K Takeyasu, M M Mouradian, P A Jose and R A Felder
      Molecular Pharmacology February 1993, 43 (2) 281-285;

  5. Horne, P

    1. Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine.
      R J Williams, M A Veale, P Horne and E Kelly
      Molecular Pharmacology February 1993, 43 (2) 158-166;

I

  1. Innis, R B

    1. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
      S C Wall, R B Innis and G Rudnick
      Molecular Pharmacology February 1993, 43 (2) 264-270;

J

  1. Jordan, S J

    1. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
      M J Burkitt, M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology February 1993, 43 (2) 257-263;

  2. Jose, P A

    1. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
      A Horiuchi, K Takeyasu, M M Mouradian, P A Jose and R A Felder
      Molecular Pharmacology February 1993, 43 (2) 281-285;

K

  1. Kadiiska, M B

    1. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
      M J Burkitt, M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology February 1993, 43 (2) 257-263;

  2. Kaminsky, L S

    1. Rat small intestinal cytochromes P450 probed by warfarin metabolism.
      M J Fasco, J B Silkworth, D A Dunbar and L S Kaminsky
      Molecular Pharmacology February 1993, 43 (2) 226-233;
    2. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
      L S Kaminsky, S M de Morais, M B Faletto, D A Dunbar and J A Goldstein
      Molecular Pharmacology February 1993, 43 (2) 234-239;

  3. Kelly, E

    1. Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine.
      R J Williams, M A Veale, P Horne and E Kelly
      Molecular Pharmacology February 1993, 43 (2) 158-166;

  4. Kemp, J A

    1. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      K A Wafford, P J Whiting and J A Kemp
      Molecular Pharmacology February 1993, 43 (2) 240-244;

  5. Kitagawa, H

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  6. Knaus, H G

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  7. Kojo, H

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  8. Kroeger, P E

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

L

  1. Lakitsch, M

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  2. Latham, M D

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

  3. Lee, H C

    1. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
      T K Chatterjee, J A Moy, J J Cai, H C Lee and R A Fisher
      Molecular Pharmacology February 1993, 43 (2) 167-175;

  4. Lee, S W

    1. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
      Y Amano, S W Lee and A C Allison
      Molecular Pharmacology February 1993, 43 (2) 176-182;

  5. Li, M

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  6. Lopez-de-Brinas, E

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

M

  1. Mahr, G

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  2. Manaut, F

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  3. Martin, A W

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

  4. Mason, R P

    1. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
      M J Burkitt, M B Kadiiska, P M Hanna, S J Jordan and R P Mason
      Molecular Pharmacology February 1993, 43 (2) 257-263;

  5. Merchant, M

    1. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
      M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
      Molecular Pharmacology February 1993, 43 (2) 200-206;

  6. Mocchetti, I

    1. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system.
      P Follesa and I Mocchetti
      Molecular Pharmacology February 1993, 43 (2) 132-138;

  7. Moebius, F F

    1. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action.
      F F Moebius, G G Burrows, J Striessnig and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 139-148;

  8. Morrison, V

    1. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
      M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
      Molecular Pharmacology February 1993, 43 (2) 200-206;

  9. Motohashi, K

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  10. Mouradian, M M

    1. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
      A Horiuchi, K Takeyasu, M M Mouradian, P A Jose and R A Felder
      Molecular Pharmacology February 1993, 43 (2) 281-285;

  11. Moy, J A

    1. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
      T K Chatterjee, J A Moy, J J Cai, H C Lee and R A Fisher
      Molecular Pharmacology February 1993, 43 (2) 167-175;

N

  1. Nakamura, K

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  2. Nakamura, T

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  3. Nakanishi, S

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  4. Nirei, H

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  5. North, R A

    1. Functional expression of adenosine A2b receptor in Xenopus oocytes.
      J L Yakel, R A Warren, S M Reppert and R A North
      Molecular Pharmacology February 1993, 43 (2) 277-280;

  6. Notsu, Y

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

O

  1. Ohmori, S

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  2. Onaran, H O

    1. Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
      H O Onaran, T Costa and D Rodbard
      Molecular Pharmacology February 1993, 43 (2) 245-256;

  3. Ono, T

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  4. Oswald, R E

    1. Identification of the benzomorphan opiate binding site on the catalytic subunit of acetylcholinesterase.
      B A Coleman and R E Oswald
      Molecular Pharmacology February 1993, 43 (2) 217-225;

P

  1. Pernet, A G

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

R

  1. Reppert, S M

    1. Functional expression of adenosine A2b receptor in Xenopus oocytes.
      J L Yakel, R A Warren, S M Reppert and R A North
      Molecular Pharmacology February 1993, 43 (2) 277-280;

  2. Rikihisa, T

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  3. Ring, P C

    1. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
      P C Ring, P M Seldon, P J Barnes and M A Giembycz
      Molecular Pharmacology February 1993, 43 (2) 302-312;

  4. Rodbard, D

    1. Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
      H O Onaran, T Costa and D Rodbard
      Molecular Pharmacology February 1993, 43 (2) 245-256;

  5. Romanin, C

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  6. Rowe, T C

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

  7. Rubin, R P

    1. Regulation of phosphatidylinositol 4-kinase activity in rat pancreatic acini.
      B R Conway, M Withiam-Leitch and R P Rubin
      Molecular Pharmacology February 1993, 43 (2) 286-292;

  8. Rudnick, G

    1. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
      S C Wall, R B Innis and G Rudnick
      Molecular Pharmacology February 1993, 43 (2) 264-270;
    2. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
      G Rudnick and S C Wall
      Molecular Pharmacology February 1993, 43 (2) 271-276;

S

  1. Safe, S

    1. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
      M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
      Molecular Pharmacology February 1993, 43 (2) 200-206;

  2. Santostefano, M

    1. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
      M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
      Molecular Pharmacology February 1993, 43 (2) 200-206;

  3. Sanz, F

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  4. Satkus, S A

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  5. Schindler, H

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  6. Seldon, P M

    1. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
      P C Ring, P M Seldon, P J Barnes and M A Giembycz
      Molecular Pharmacology February 1993, 43 (2) 302-312;

  7. Shirakawa, C

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;

  8. Shoubo, M

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  9. Silkworth, J B

    1. Rat small intestinal cytochromes P450 probed by warfarin metabolism.
      M J Fasco, J B Silkworth, D A Dunbar and L S Kaminsky
      Molecular Pharmacology February 1993, 43 (2) 226-233;

  10. Sogabe, K

    1. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
      I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
      Molecular Pharmacology February 1993, 43 (2) 127-131;

  11. Sörgel, F

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  12. Spagnola, B V

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  13. Striessnig, J

    1. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action.
      F F Moebius, G G Burrows, J Striessnig and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 139-148;
    2. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

  14. Strobl, G

    1. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
      U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
      Molecular Pharmacology February 1993, 43 (2) 191-199;

  15. Sullivan, D M

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

T

  1. Takeyasu, K

    1. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
      A Horiuchi, K Takeyasu, M M Mouradian, P A Jose and R A Felder
      Molecular Pharmacology February 1993, 43 (2) 281-285;

  2. Topar, G

    1. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
      M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
      Molecular Pharmacology February 1993, 43 (2) 293-301;

V

  1. Veale, M A

    1. Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine.
      R J Williams, M A Veale, P Horne and E Kelly
      Molecular Pharmacology February 1993, 43 (2) 158-166;

W

  1. Wafford, K A

    1. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      K A Wafford, P J Whiting and J A Kemp
      Molecular Pharmacology February 1993, 43 (2) 240-244;

  2. Wall, S C

    1. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
      S C Wall, R B Innis and G Rudnick
      Molecular Pharmacology February 1993, 43 (2) 264-270;
    2. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
      G Rudnick and S C Wall
      Molecular Pharmacology February 1993, 43 (2) 271-276;

  3. Wall, S J

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  4. Warren, R A

    1. Functional expression of adenosine A2b receptor in Xenopus oocytes.
      J L Yakel, R A Warren, S M Reppert and R A North
      Molecular Pharmacology February 1993, 43 (2) 277-280;

  5. Webb, C D

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

  6. Weisstein, J S

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  7. Wellhausen, S R

    1. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
      D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
      Molecular Pharmacology February 1993, 43 (2) 207-216;

  8. Whiting, P J

    1. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      K A Wafford, P J Whiting and J A Kemp
      Molecular Pharmacology February 1993, 43 (2) 240-244;

  9. Williams, R J

    1. Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine.
      R J Williams, M A Veale, P Horne and E Kelly
      Molecular Pharmacology February 1993, 43 (2) 158-166;

  10. Withiam-Leitch, M

    1. Regulation of phosphatidylinositol 4-kinase activity in rat pancreatic acini.
      B R Conway, M Withiam-Leitch and R P Rubin
      Molecular Pharmacology February 1993, 43 (2) 286-292;

  11. Wolfe, B B

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

Y

  1. Yakel, J L

    1. Functional expression of adenosine A2b receptor in Xenopus oocytes.
      J L Yakel, R A Warren, S M Reppert and R A North
      Molecular Pharmacology February 1993, 43 (2) 277-280;

  2. Yasuda, R P

    1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
      R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
      Molecular Pharmacology February 1993, 43 (2) 149-157;

  3. Yoshida, H

    1. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
      S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
      Molecular Pharmacology February 1993, 43 (2) 183-190;
Back to top

In this issue

Advertisement